Clinical Trials Directory

Trials / Completed

CompletedNCT03481257

Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel

Comparison of Shear Stress-induced Thrombotic and Thrombolytic Effect d Thrombolytic Effect Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel in Patients With Acute Coronary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A total of 50 participants diagnosed with ACS (group A ticagrelor 180mg/d, n=25), group B (clopidogrel 75mg + rivaroxaban 5mg/ d, n=25)) were consecutively enrolled and treated with study drugs on top of aspirin (100mg/d) for 1 month. VerifyNow® and Global thrombosis test were performed at day 2 and 1 month after administration of study drugs. The investigators compared aspirin reaction unit (ARU) and P2Y12 reaction unit (PRU), occlusion time (OT) which reflects shear stress-induced thrombotic activity, and lysis time (LT) which showed endogenous lytic activity between the two strategies at both time points.

Conditions

Timeline

Start date
2017-04-12
Primary completion
2018-01-04
Completion
2018-02-04
First posted
2018-03-29
Last updated
2018-03-29

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03481257. Inclusion in this directory is not an endorsement.

Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel (NCT03481257) · Clinical Trials Directory